Latuda 60 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FJLFK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,252
Award facts
- Contract value 100% obligated
- $10,251.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,251.90 by the Defense Logistics Agency for the supply of Latuda 60 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 16, 2025, with completion scheduled for September 17, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing the vendor to compete on its merits within the DLA's pharmaceutical supply framework.
This delivery order is executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which authorizes firm fixed-price orders for a comprehensive range of pharmaceutical products supporting medical supply requirements across Department of Defense healthcare facilities worldwide. The parent IDC encompasses branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription medications and pharmacy services to military health facilities, with Latuda (lurasidone hydrochloride) being an atypical antipsychotic utilized in military medical settings.
Quick answers
Who was awarded contract SPE2DB25FJLFK?
SPE2DB25FJLFK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FJLFK worth?
The government has obligated $10,252 on SPE2DB25FJLFK.
Is contract SPE2DB25FJLFK an order under another contract?
Yes. SPE2DB25FJLFK is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLFK competed?
The extent of competition for SPE2DB25FJLFK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award